| Name | Title | Contact Details |
|---|
Get in shape, build strength, tone, and lose weight, faster with BurnAlong.
Excelsior Medical is a privately held medical device company with a primary focus on innovative IV catheter maintenance products that may reduce infection, medication errors and healthcare costs. The company manufactures and sells SwabCap and SwabFlush for the disinfection and protection of IV needleless connectors. Formed in 1989, Excelsior also manufactures and sells prefilled saline flush syringes, prefilled heparin flush and lock syringes, and syringe pump systems.
TBH is a leading provider of behavioral health services. We specialize in the treatment of children and adults with Autism Spectrum Disorders and developmental disabilities, using the principles of Applied Behavior Analysis (ABA). TBH is proud to employ a talented staff dedicated to its mission and values, constructing a team of experienced, caring and enthusiastic individuals to coordinate the best behavior program possible for children, adults and families. Further, TBH`s collaborative efforts mean that parents, schools, agencies, Supervisors and Skills Trainers all play important roles in behavior programs, forming a large team dedicated to the needs of each client. TBH employs many Board Certified Behavior Analysts, and each Behavioral Consultant, also known as a Supervisor, is carefully screened to meet the qualifications set forth by TBH as well as those of the Behavior Analyst Certification Board (BACB). Further, each Skills Trainer, also known as a Paraprofessional, is screened using the same criteria. Behavioral Consultants and Skills Trainers are selected for clients on a case-by-case basis with careful consideration given to education, level of experience, and personality compatibility with the family and child.
Mr. Gallagher is Senior Vice President & Chief Financial Officer at RRD International, LLC. Mr. Gallagher provides strategic, operational, and financial leadership to RRD. His primary responsibilities are planning, implementing, managing, and controlling all financial-related activities including the development of financial and operational strategies. Mr. Gallagher has over 20 years of finance experience in the biopharma industry with both multi-national corporations and commercial-stage public biotechnology companies. He has an extensive background in all areas of corporate controllership, including financial planning & analysis, cost control, management accounting, corporate administration, and systems implementation. He has supported all aspects of product development and commercialization, including the negotiation and execution of licensing and collaboration agreements with major pharma partners. Mr. Gallagher served previously as Vice President of Finance for Optimer Pharmaceuticals and, prior to that, as Senior Director of Finance and Corporate Controller for Adolor Corporation. He had a central role in the sale of both companies. Mr. Gallagher spent the first 10 years of his career with Therakos, Inc. (a Johnson & Johnson company) and Merck & Co., Inc. He received his BS in Finance from The Pennsylvania State University and is an active Certified Management Accountant (CMA).
Ryogen is a Suffern, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.